Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
They CRISPR’ed tomatoes to make them sweet and large
Today’s mass-produced tomatoes often grow to palm-sized proportions, but their naturally occurring ancestors were far smaller fruits. They were also sweeter and more flavorful due to their lower water content compared to the red fruits found in grocery stores—but recent genetic discoveries have unlocked the path to attaining the best of both worlds.
New study using CRISPR technology reveals a way to make tomatoes sweeter without sacrificing yield.
They realized that if they “release” these breaks, tomatoes could become much sweeter. They used
CRISPR
-Cas9 gene-editing technology to “knock out” these genes in several tomato varieties. The results were impressive. Sugar levels, particularly ...
Sweet CRISPR Tomatoes May Be Coming to a Supermarket Near You
Using CRISPR, the popular gene-editing tool, scientists bumped up the fruit’s sugar content by 30 percent without sacrificing size or yields.
Sweeter tomatoes are coming soon thanks to CRISPR gene editing
Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them sweeter without decreasing yields
Chinese scientists modify tomatoes to make them ‘significantly sweeter’
Glucose and fructose levels were 30 per cent higher after researchers removed two genes that regulate sugar content, according to study Chinese scientists have successfully modified tomatoes to make them sweeter by removing two genes that regulate sugar content,
2d
The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
STAT
22h
Intellia says CRISPR therapy shows superior gain for cardiomyopathy patients
Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.
2d
Where Will CRISPR Therapeutics Be in 3 Years?
CRISPR Therapeutics ( CRSP -5.91%) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior ...
Nature
4d
CRISPR builds a big tomato that’s actually sweet
Rotten tomatoes no more: growing sweeter tomatoes is possible by editing just two of the fruit’s genes. Deleting the genes ...
5d
on MSN
New CRISPR system for gene silencing doesn't rely on cutting DNA
Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...
5d
Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
2d
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
EST Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...
10d
on MSN
Genetic repair via CRISPR can inadvertently introduce other defects, researchers show
The CRISPR molecular scissors have the potential to revolutionize the treatment of genetic diseases. This is because they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback